Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk.
Saved in:
| Title: | Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk. |
|---|---|
| Authors: | Sarkar S; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC, USA. ss4235@georgetown.edu., Schechter C; Department of Family and Social Medicine, Albert Einstein College of Medicine, New York City, NY, USA., Kurian AW; Department of Medicine (Oncology) and Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA., Caswell-Jin JL; Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA., Jayasekera J; Health Equity and Decision Sciences Laboratory, National Institute on Minority Health and Health Disparities, National Institutes of Health, Rockville, MD, USA., Mandelblatt JS; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC, USA.; Georgetown Lombardi Institute for Cancer and Aging REsearch (I-CARE), Lombardi Comprehensive Cancer Center, Washington, DC, USA. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2025 Mar 26; Vol. 11 (1), pp. 30. Date of Electronic Publication: 2025 Mar 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-025-00746-7 |
